EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Extra Virgin Olive Oil: Molecular Mechanisms, Bioavailability Challenges, and Therapeutic Perspectives

Muhammad Maaz iD, Muhammad Tauseef Sultan iD, Ahmad Mujtaba Noman iD, Ralf Weiskirchen iD, Waleed Rizk ElGhareeb iD, Bodour Ibrahim Al Shik Mubarak, Adel A Rezk iD, Marwa Ezz El-Din Ibrahim iD

Nutrients · 24.07.2026 · 18 (15) · 2416

DOI: 10.3390/nu18152416 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 24.07.2026. Verfasst von Muhammad Maaz und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Nutrition, Faculty of Food Science and Nutrition, Bahauddin Zakariya University, Multan 60800, Pakistan. Hauptthemen laut MEDLINE: Olive Oil, Neoplasms. Die Arbeit nennt 148 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King Faisal University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Extra virgin olive oil (EVOO), a key component of the Mediterranean diet, has attracted research interest because olive-derived phenolics demonstrate potential anticancer activity in experimental models. This review summarizes evidence concerning whole EVOO, phenolic-enriched EVOO, olive phenolic extracts, and the isolated compounds hydroxytyrosol, oleuropein, oleocanthal, and oleacein.

Methods

A structured narrative search of PubMed, Web of Science, ScienceDirect, and Google Scholar was conducted for literature published between 2015 and 2025. Evidence was reviewed for breast, prostate, colorectal, pancreatic, bone, oral, liver, gastric, hematological, and brain cancers. Comparatively limited evidence concerning cervical, endometrial, ovarian, melanoma, non-melanoma skin, and thyroid cancers was summarized separately.

Results

The molecular evidence was derived primarily from cell culture and animal studies using isolated phenolics and concentrated extracts. Preclinical studies indicate that EVOO phenolics may demonstrate anticancer activity through multiple mechanisms, including antioxidant activity, anti-inflammatory effects, cell cycle arrest, induction of apoptosis, inhibition of metastasis, anti-angiogenic activity, and modulation of key signaling pathways, such as PI3K/AKT/mTOR, MAPK/ERK, NF-κB, JAK/STAT, Wnt/β-catenin, p53, and epithelial–mesenchymal transition-related pathways. Most molecular and pathway-level evidence was obtained using isolated phenolic compounds in cell culture or animal models, whereas evidence directly examining whole EVOO consumption was largely observational and substantially more limited. Experimental studies also reported that oleocanthal induced lysosomal membrane permeabilization, whereas hydroxytyrosol and oleuropein promoted mitochondria-mediated apoptosis. Furthermore, preclinical combination studies suggested enhanced tumor-cell sensitivity to selected chemotherapeutic, targeted, and immunotherapeutic agents. However, these effects have not been established in patients. Human evidence remains limited mainly to observational dietary associations and small exploratory interventions, with no conclusive demonstration of cancer prevention or therapeutic efficacy.

Conclusions

Isolated EVOO-derived phenolic compounds demonstrated promising anticancer mechanisms in preclinical models. However, these results should not be directly extrapolated to dietary EVOO because experimentally administered doses, bioavailability, metabolism, and food-matrix interactions differ substantially from human dietary exposure. Therefore, well-designed studies using chemically characterized EVOO, pharmacokinetic investigations, and controlled human trials are required before dietary or clinical recommendations can be made.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Olive OilNeoplasmsHumansAnimalsPhenolsCyclopentane MonoterpenesBiological AvailabilityIridoid GlucosidesAntioxidantsPhenylethyl AlcoholAldehydesPlant ExtractsApoptosisDiet, Mediterranean

Stichwörter der Autor:innen

anticancerapoptosis inductionbioavailabilityextra virgin olive oilolive phenolicspreclinical evidencesignaling pathways

Substanzen

Olive OilPhenolsoleocanthalCyclopentane Monoterpenes3,4-dihydroxyphenylethanololeuropeinIridoid GlucosidesAntioxidantsoleaceinPhenylethyl Alcohol

Autor:innen und Institutionen

  • Department of Human Nutrition, Faculty of Food Science and Nutrition, Bahauddin Zakariya University, Multan 60800, Pakistan.
  • Institute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry (IFMPEGKC), RWTH University Hospital Aachen, 52074 Aachen, Germany.
  • Department of Public Health, College of Veterinary Medicine, King Faisal University, Al-Ahsa 31982, Saudi Arabia.
  • Department of Food and Nutrition Science, College of Agricultural and Food Sciences, King Faisal University, Al-Ahsa 31982, Saudi Arabia.
  • Agricultural Biotechnology Department, College of Agricultural and Food Science, King Faisal University, Al-Ahsa 31982, Saudi Arabia.

ORCID-Profile: Muhammad Maaz, Muhammad Tauseef Sultan, Ahmad Mujtaba Noman, Ralf Weiskirchen, Waleed Rizk ElGhareeb, Adel A Rezk, Marwa Ezz El-Din Ibrahim

Förderung

  • King Faisal University

Zitieren

APA

Maaz, M., Sultan, M. T., Noman, A. M., Weiskirchen, R., ElGhareeb, W. R., Mubarak, B. I. A. S., Rezk, A. A., & Ibrahim, M. E. E. (2026). Extra Virgin Olive Oil: Molecular Mechanisms, Bioavailability Challenges, and Therapeutic Perspectives. Nutrients, 18(15), 2416. https://doi.org/10.3390/nu18152416

Vancouver

Maaz M, Sultan MT, Noman AM, Weiskirchen R, ElGhareeb WR, Mubarak BIAS, et al. Extra Virgin Olive Oil: Molecular Mechanisms, Bioavailability Challenges, and Therapeutic Perspectives. Nutrients. 2026;18(15):2416. doi:10.3390/nu18152416

BibTeX
@article{Maaz2026,
  author = {Maaz, Muhammad and Sultan, Muhammad Tauseef and Noman, Ahmad Mujtaba and Weiskirchen, Ralf and ElGhareeb, Waleed Rizk and Mubarak, Bodour Ibrahim Al Shik and Rezk, Adel A and Ibrahim, Marwa Ezz El-Din},
  title = {Extra Virgin Olive Oil: Molecular Mechanisms, Bioavailability Challenges, and Therapeutic Perspectives},
  journal = {Nutrients},
  year = {2026},
  volume = {18},
  number = {15},
  pages = {2416},
  doi = {10.3390/nu18152416}
}
Kostenlos starten →